Abstract
Recombinant phenotyping of cytomegalovirus (CMV) pol region III mutations from clinical specimens showed that T813S and G841A each conferred foscarnet resistance and approximately threefold increased ganciclovir resistance; adding the UL97 mutation C592G increased ganciclovir resistance to approximately sixfold. Bacterial artificial chromosome CMV clones containing pol mutation L845P were nonviable unless repaired with the wild-type sequence.
Original language | English (US) |
---|---|
Pages (from-to) | 4160-4162 |
Number of pages | 3 |
Journal | Antimicrobial agents and chemotherapy |
Volume | 51 |
Issue number | 11 |
DOIs | |
State | Published - Nov 2007 |
Externally published | Yes |
ASJC Scopus subject areas
- Pharmacology
- Pharmacology (medical)
- Infectious Diseases